AQST - CIK 0001398733
The table below shows Aquestive Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | $31.81M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $6.17M | $6.04M | $6.77M | $5.78M | $4.04M | $2.46M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $149.27M |
| $88.22M |
| $40.97M |
| $39.89M |
| $47.26M |
| $44.63M |
| Property, plant & equipment | $3.89M | $3.80M | $4.18M | $4.08M | $5.05M | $6.87M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $160.43M | $101.42M | $57.42M | $57.07M | $61.99M | $62.88M |
| Accounts payable | $29.86M | $10.29M | $8.93M | $9.95M | $8.31M | $7.09M |
| Total current liabilities | $47.61M | $18.86M | $18.31M | $39.53M | $21.96M | $21.10M |
| Long-term debt | $45.00M | $45.00M | $45.00M | - | - | $51.50M |
| Total liabilities | $194.09M | $161.58M | $163.91M | $175.62M | $144.13M | $111.38M |
| Retained earnings | -$447.00M | -$363.21M | -$319.08M | -$311.21M | -$256.80M | -$186.26M |
| Total equity | -$33.66M | -$60.16M | -$106.49M | -$118.55M | -$82.13M | -$48.50M |